<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02315014</url>
  </required_header>
  <id_info>
    <org_study_id>12.12.NRC</org_study_id>
    <nct_id>NCT02315014</nct_id>
  </id_info>
  <brief_title>Daily Protein Intake Distribution and MPS (ARCIII)</brief_title>
  <official_title>Effect of Balanced Daily Protein Distribution Supplemented With Whey Protein on Muscle Protein Synthesis in Overweight Older Men During Calorie Restriction and Exercise (ARC III)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether a balanced total daily dietary protein distribution supplemented with&#xD;
      whey protein during a weight-loss intervention will result in increased muscle protein&#xD;
      synthesis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>muscle protein synthesis</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>protein synthesis is evaluated in muscle biopsy tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>body composition is evaluated using DEXA</measure>
    <time_frame>up to 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>whey protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>whey protein micelles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>calorie-free placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>whey protein</intervention_name>
    <description>whey protein.</description>
    <arm_group_label>whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Overweight/obese (BMI 27-40 kg/m2)&#xD;
&#xD;
          -  Non-smokers&#xD;
&#xD;
          -  Non-diabetic&#xD;
&#xD;
          -  No history of hyperlipidemia&#xD;
&#xD;
          -  Not taking medications thought to interfere with study&#xD;
&#xD;
          -  Considered generally healthy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Efforts to lose weight in previous 16 weeks&#xD;
&#xD;
          -  Hyperlipidemia&#xD;
&#xD;
          -  Blood pressure ≥ 140/90 mmHg&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Heart and other organ disease&#xD;
&#xD;
          -  Type 2 diabetes&#xD;
&#xD;
          -  Gastrointestinal disease&#xD;
&#xD;
          -  Orthopedic injury interfering with exercise&#xD;
&#xD;
          -  Use of certain medications (HRT, antihypertensives, diuretics, antiarythmia&#xD;
             medications, antiresorptive agents, anabolic agents, hypoglycemic agents, and statins&#xD;
             known to affect muscle i.e. Simvastatin and Zocor)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Phillips, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>November 13, 2014</study_first_submitted>
  <study_first_submitted_qc>December 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2014</study_first_posted>
  <last_update_submitted>December 10, 2014</last_update_submitted>
  <last_update_submitted_qc>December 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

